Table 3.
Demographic data of patients with upper respiratory tract infection by pathogen.
| Infecting viruses | Number of patients | Age (years) | Gender | |||||
|---|---|---|---|---|---|---|---|---|
| Number (%) | Number (%) | |||||||
| <15 | 15–24 | 25–34 | 35–44 | >45 | Male | Female | ||
| Total number | 75 | 26 (34.7) | 16 (21.3) | 15 (20.0) | 13 (17.3) | 5 (6.7) | 54 (72.0) | 21 (28.0) |
| hRV | 29 | 5 (19.2) | 6 (37.5) | 9 (60.0) | 5 (38.5) | 4 (80.0) | 24 (82.8) | 5 (17.2) |
| hCoV-OC43 | 9 | 3 (11.5) | 1 (6.3) | 1 (6.66) | 4 (30.8) | 0 | 7 (77.8) | 2 (22.2) |
| hCoV-HKU1 | 2 | 1 (3.8) | 0 | 0 | 0 | 1 (20.0) | 0 | 2 (100) |
| hCoV-NL63 | 1 | 1 (3.8) | 0 | 0 | 0 | 0 | 1 (100) | 0 |
| hRSV-A | 1 | 0 | 1 (6.3) | 0 | 0 | 0 | 1 (100) | 0 |
| hRSV-B | 7 | 5 (19.2) | 2 (12.5) | 0 | 0 | 0 | 4 (57.1) | 3 (42.9) |
| FluA | 7 | 2 (7.7) | 1 (6.3) | 2 (13.33) | 2 (15.4) | 0 | 5 (71.4) | 2 (28.6) |
| FluB | 2 | 1 (3.8) | 0 | 1 (6.66) | 0 | 0 | 1 (50) | 1 (50) |
| EV | 2 | 2 (7.7) | 0 | 0 | 0 | 0 | 1 (50) | 1 (50) |
| hAdv | 1 | 0 | 1 (6.3) | 0 | 0 | 0 | 1 (100) | 0 |
| hMPVA | 1 | 0 | 0 | 1 (6.66) | 0 | 0 | 1 (100) | 0 |
| hRV + FluA | 1 | 0 | 1 (6.3) | 0 | 0 | 0 | 1 (100) | 0 |
| hAdv + hRV | 4 | 2 (7.7) | 1 (6.3) | 1 (6.66) | 0 | 0 | 2 (50) | 2 (50) |
| hCoV-OC43 + FluA | 3 | 1 (3.8) | 1 (6.3) | 0 | 1 (7.7) | 0 | 3 (100) | 0 |
| hRV + hRSV-A | 1 | 1 (3.8) | 0 | 0 | 0 | 0 | 1 (100) | 0 |
| hRSV-A + hRSV-B | 1 | 1 (3.8) | 0 | 0 | 0 | 0 | 0 | 1 (100) |
| hCoV-OC43 + hRSV-B | 1 | 0 | 1 (6.3) | 0 | 0 | 0 | 1 (100) | 0 |
| FluA + EV | 1 | 1 (3.8) | 0 | 0 | 0 | 0 | 0 | 1 |
| hCoV-OC43 + hRV | 1 | 0 | 0 | 0 | 1 (7.7) | 0 | 0 | 1 |